Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cassava Sciences Inc

1.61
-0.0100-0.62%
Post-market: 1.60-0.0100-0.62%19:57 EDT
Volume:435.09K
Turnover:707.13K
Market Cap:77.78M
PE:-1.10
High:1.67
Open:1.64
Low:1.60
Close:1.62
Loading ...
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 | Cassava Sciences' Officer Eric Schoen proposes to sell 2000 Shares, with a total value of approximately $7640.
Nov 29, 2024

Proposed Sale Of Securities

Form 144 | CASSAVA SCIENCES INC's Officer Schoen Eric proposes to sell 59800 Shares, with a total value of approximately $230965.85.
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]